Lupron depot 11.25 MG 3MO kits
Ended Awarded Last action
- Contract number
- SPE2DR26FCV6Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,646
Award facts
- Contract value 100% obligated
- $39,646.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits with a ceiling value of $39,646.39. This firm fixed-price, competitively awarded contract was issued on December 18, 2025, with an ultimate completion date of December 19, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. Lupron Depot is a prescription hormone therapy medication primarily used in treating prostate cancer, endometriosis, and other hormone-responsive conditions, representing specialized pharmaceutical procurement for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside award demonstrates the contractor's continued capability to meet federal procurement requirements through open competition and its essential role in sustaining military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FCV6Z?
SPE2DR26FCV6Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FCV6Z worth?
The government has obligated $39,646 on SPE2DR26FCV6Z.
Is contract SPE2DR26FCV6Z an order under another contract?
Yes. SPE2DR26FCV6Z is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV6Z competed?
The extent of competition for SPE2DR26FCV6Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award